Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction

por Baird, R, Biondo, A, Chhaya, V, McLachlan, J, Karpathakis, A, Rahman, S, Barbachano, Y, Cunningham, D, Chau, I
Publicado 2011

P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA.

por Sims, M., Ward, G., Zhang, Z., Jueliger, S., Davis, M., Boxall, A., Taylor, J., Biondo, A., Lyons, J., Smyth, T.
Publicado 2022

A novel methodology for epidemic risk assessment of COVID-19 outbreak

por Pluchino, A., Biondo, A. E., Giuffrida, N., Inturri, G., Latora, V., Le Moli, R., Rapisarda, A., Russo, G., Zappalà, C.
Publicado 2021

Author Correction: A novel methodology for epidemic risk assessment of COVID-19 outbreak

por Pluchino, A., Biondo, A. E., Giuffrida, N., Inturri, G., Latora, V., Le Moli, R., Rapisarda, A., Russo, G., Zappalà, C.
Publicado 2021